Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
J Toxicol Clin Toxicol ; 38(5): 477-82, 2000.
Article in English | MEDLINE | ID: mdl-10981957

ABSTRACT

BACKGROUND: The radiopacity of ingested substances may serve as a clue to the presence of particular compounds, as this characteristic varies considerably among medications and household products. Tablet conglomerations are also variably radiopaque. We report 4 cases of clomipramine poisoning associated with formation of radiopaque masses, believed to be clomipramine, in the area of the stomach. CASE REPORTS: Four patients were admitted to the Toxicological Intensive Care Unit after ingestions of, respectively, 8.5 g (180 tablets of mixed strength), 7.5 g (100 tablets), 10.5 g (140 tablets), and 4.5 g (60 tablets) of clomipramine, along with other sedatives and antipsychotics. In each case, a rounded density was observed in the gastric area on plain chest radiograph. The hospital courses of each patient were marked by tachycardia, hypotension, QRS and QT prolongation, seizures, and decreased mental status. Three of 4 patients underwent unsuccessful endoscopy to remove tablet fragments and subsequently suffered gastrointestinal hemorrhage requiring transfusion. All patients were discharged recovered from the hospital. DISCUSSION: Clomipramine, a potent tricyclic antidepressant, has been previously reported to be nonradiopaque, and has not been reported to induce formation of concretions. These cases suggest that massive ingestions of clomipramine may form bezoars which are radiopaque and may be associated with serious toxicity. Careful consideration should be given prior to the use of gastric endoscopy for the retrieval of tablet fragments since significant hemorrhage, attributed to the procedure itself rather than to clomipramine toxicity, may ensue.


Subject(s)
Acepromazine/analogs & derivatives , Antidepressive Agents, Tricyclic/poisoning , Clomipramine/poisoning , Stomach/diagnostic imaging , Acepromazine/chemistry , Acepromazine/poisoning , Adult , Antidepressive Agents, Tricyclic/chemistry , Antidepressive Agents, Tricyclic/pharmacokinetics , Azabicyclo Compounds , Bromazepam/chemistry , Bromazepam/poisoning , Clomipramine/chemistry , Clomipramine/pharmacokinetics , Gastric Mucosa/metabolism , Gastroscopy/methods , Humans , Lorazepam/chemistry , Lorazepam/poisoning , Male , Middle Aged , Piperazines/chemistry , Piperazines/poisoning , Poisoning/diagnostic imaging , Poisoning/metabolism , Prazepam/chemistry , Prazepam/poisoning , Pyridines/chemistry , Pyridines/poisoning , Radiography , Tablets , Zolpidem
2.
J Pharm Biomed Anal ; 17(4-5): 739-50, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9682158

ABSTRACT

A reversed-phase HPLC method was developed for the kinetic investigation of the acidic hydrolysis of prazepam which was carried out in hydrochloric acid solutions of 0.01, 0.1 and 1.0 M. In addition, a fourth-order derivative method for monitoring the parent compound itself was proposed and evaluated. One intermediate was observed by HPLC, which should be formed from breakage of the azomethine linkage. Further slow hydrolysis of the amide bond led to the benzophenone product that was isolated and identified. The mechanism of hydrolysis was biphasic, showing a consecutive reaction with a reversible step. Relative standard deviation was less than 2% for HPLC and less than 5% for the derivative method. Detection limits were 1.2 x 10(-7) M for the former method and 6.7 x 10(-7)M for the latter. Accelerated studies at higher temperatures were employed. Results of HPLC and fourth-order derivative methods were statistically the same.


Subject(s)
Anti-Anxiety Agents/chemistry , Chromatography, High Pressure Liquid/methods , Prazepam/chemistry , Spectrophotometry, Ultraviolet/methods , Hydrogen-Ion Concentration , Kinetics , Molecular Structure , Reproducibility of Results , Solutions
3.
Bioorg Med Chem ; 2(10): 1029-49, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7773620

ABSTRACT

Semiempirical quantum mechanical and molecular mechanics calculations were carried out to identify and characterize the steric and electronic properties that modulate ligand recognition and activation of the cerebellar GABAA/benzodiazepine (BDZ) receptor. For this hypothesis development, thirteen compounds belonging to structurally diverse chemical families were selected for study. Among the compounds selected were nine that bind and four that do not bind with appreciable affinity to this receptor and some that are known agonists, antagonists and inverse agonists, as measured by their modulation of GABA (gamma-aminobutyric acid) enhanced chloride ion flux in cerebellum. The stereoelectronic requirements for recognition deduced from commonalities among the ligands are the presence of at least two of three hydrogen bonding centers, and a lipophilic aromatic ring, in a specific spatial relationship. The results suggest that the selectivity for the cerebellar or Type I subtype, demonstrated by some of these ligands, could be failure to meet the requirements for binding at other receptors because of the absence of one of the proton accepting centers or the larger surface area and volume of these ligands. The requirement for activation, deduced from comparisons of agonist, antagonist, and inverse agonist properties is the presence of an electron accepting aromatic ring in a specific geometric arrangement with respect to the components of recognition. The validity of the '3D-Pharmacophore' developed was probed by using it for predictions of the behavior of 11 additional compounds not used for its development.


Subject(s)
Benzodiazepines/chemistry , Cerebellum/chemistry , Receptors, GABA-A/chemistry , Animals , Benzodiazepines/pharmacology , Electrochemistry , GABA-A Receptor Antagonists , Isoquinolines/chemistry , Ligands , Models, Molecular , Molecular Structure , Prazepam/chemistry , Rats , Receptors, GABA-A/metabolism , Structure-Activity Relationship , Thermodynamics
4.
J Forensic Sci ; 37(2): 460-6, 1992 Mar.
Article in English | MEDLINE | ID: mdl-1354247

ABSTRACT

Solid-phase extraction (SPE) by means of disposable columns has become a widely accepted technique for sample pretreatment in toxicology, both for directed analyses and for screening analyses. However, the sample capacity in SPE is usually limited to a few millilitres. Therefore, we have investigated to what extent these problems can be overcome by using Empore extraction disks, consisting of chemically modified C-8 reversed-phase silica, embedded in an inert polytetrafluoroethylene (PTFE) matrix. Human urine was selected as the matrix and dexetimide and mepyramine were initially used as test drugs because these drugs were available in tritiated form. Additional drugs investigated included codeine, hexobarbital, imipramine, methamphetamine, and nitrazepam. In these investigations, the sample capacity for untreated urine was at least 25 mL, and analyte quantities up to 250 micrograms could be retained by these filters. Washing with water/methanol mixtures was successful in removing substantial amounts of endogenous interferences, and methanol proved to be an acceptable eluent. Thus, these disks seem to have interesting potential for toxicological analysis in that sample concentration and cleanup can be achieved at the same time.


Subject(s)
Dexetimide/urine , Pyrilamine/urine , Barbiturates/chemistry , Barbiturates/isolation & purification , Barbiturates/urine , Codeine/chemistry , Codeine/isolation & purification , Codeine/urine , Dexetimide/chemistry , Dexetimide/isolation & purification , Filtration , Hexobarbital/chemistry , Hexobarbital/isolation & purification , Hexobarbital/urine , Humans , Imipramine/chemistry , Imipramine/isolation & purification , Imipramine/urine , Methamphetamine/chemistry , Methamphetamine/isolation & purification , Methamphetamine/urine , Molecular Structure , Nitrazepam/chemistry , Nitrazepam/isolation & purification , Nitrazepam/urine , Prazepam/chemistry , Prazepam/isolation & purification , Prazepam/urine , Pyrilamine/chemistry , Pyrilamine/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL